 |
|
|
| |
SPIRIT: Simplification to Rilpivirine/Emtricitabine/Tenofovir DF Single-Tablet Regimen from Boosted Protease Inhibitor Maintains HIV-1 Suppression and Improves Fasting Lipids at Week 48
|
| |
| |
Reported by Jules Levin
IDSA Oct 2-6 2013 San Francisco, CA
Pablo Tebas, Frank Palella, Peter Ruane, David Shamblaw, Jason Flamm, Ramin Ebrahimi, Danielle Porter, Scott Williams, Toni Sparrow, Todd Fralich, Shampa De-Oertel
|
| |
|
|
|
|
|
